Michele Viana

researcher ORCID ID = 0000-0003-4356-8109

Michele Viana is …
instance of (P31):
humanQ5

External links are
P1960Google Scholar author IDpFA61c8AAAAJ
P9844IRIS UNIPV author ID17717
P10639IRIS UNIUPO author ID01727
P496ORCID iD0000-0003-4356-8109

P108employerKing's College LondonQ245247
???Q3886624
P734family nameVianaQ21408173
VianaQ21408173
VianaQ21408173
P735given nameMicheleQ18620536
MicheleQ18620536
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q426377905-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms
Q54255093An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
Q48226245Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache
Q90451127Clinical Subtypes of Medication Overuse Headache - Findings From a Large Cohort
Q51895857Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.
Q43958385Clinical correlates of pathological gambling symptoms in patients with epilepsy.
Q39442661Clinical features of migraine aura: Results from a prospective diary-aided study
Q92413344Clinical features of visual migraine aura: a systematic review
Q52305239Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.
Q36750211Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review
Q52326074Factors associated to chronic migraine with medication overuse: A cross-sectional study.
Q54215454Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy.
Q40206672Headache in a patient with crowned dens: report of a new case
Q38001620Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
Q37075316Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
Q85753341Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans
Q84079303Localized scleroderma unius lateri and Borrelia burgdoferi infection
Q57544907Manic/hypomanic symptoms and quality of life measures in patients with epilepsy
Q37114359Measuring the level and content of consciousness during epileptic seizures: the Ictal Consciousness Inventory.
Q40757299Migraine aura symptoms: Duration, succession and temporal relationship to headache
Q48293286Migraine with prolonged aura: phenotype and treatment
Q36468440O010. Migraine aura symptoms last for more than one hour in more than one quarter of patients: results from a prospective diary-aided study
Q36468638O011. Patients with "prolonged aura" do not show clinical or demographic differences from the patients with "typical aura".
Q36468731O012. Intra-variability of the characteristics of migraine attacks
Q36468499P008. Alexithymia and chronic migraine with medication overuse: what relationship?
Q38195629Pharmacogenomics of episodic migraine: time has come for a step forward.
Q90415027Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort
Q99588832Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study
Q58782325Prolonged migraine aura: new insights from a prospective diary-aided study
Q93243577Proposal for a Migraine Aura Complexity Score
Q42921236Role of 2 common variants of 5HT2A gene in medication overuse headache
Q95926451The depiction of migraine visual aura on the internet
Q43058226The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients
Q38087899The typical duration of migraine aura: a systematic review
Q87662194Topiramate for migraine prevention in fertile women: reproductive counseling is warranted
Q37900070Trigeminal neuropathic pain in a patient with progressive facial hemiatrophy (parry-romberg syndrome).
Q38096945Triptan nonresponders: do they exist and who are they?
Q45903854Triptan use in Italy: Insights from administrative databases.
Q96030368Visual snow syndrome: a comparison between an Italian and British population
Q47612945When cervical pain is actually migraine: An observational study in 207 patients

Search more.